Global L-Arginine Market Size, Share, Growth Analysis, By Type(Food Grade, Pharma Grade), By Application(Supplements & Nutrition, Pharmaceuticals) - Industry Forecast 2022-2028

Global L-Arginine Market size was valued at USD 26.38 billion in 2021 and is poised to grow from USD 28.32 billion in 2022 to USD 49.67 billion by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

The global L-arginine market is projected to experience substantial growth in the coming years, driven by increasing demand from the food and dietary supplements industry. L-arginine is an amino acid that plays a crucial role in protein synthesis, immune system function, and the production of nitric oxide. The market is also being propelled by rising health awareness among consumers, as L-arginine is believed to have various health benefits, including reducing blood pressure and improving cardiovascular health.

Top-down and bottom-up approaches were used to estimate and validate the size of L-Arginine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global L-Arginine market is segmented based on the type, application, and region. Based on the type, it is bifurcated into food grade, and pharma grade. Based on application, it is segmented into supplements & nutrition, pharmaceuticals, cosmetics, others. Based on region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

The rising trend of health and fitness has resulted in an increased global demand for dietary supplements, including L-arginine. The popularity of arginine has grown among bodybuilders, fitness enthusiasts, and athletes, leading to the industry's growth worldwide. L-arginine is also being used to treat various health conditions such as heart failure, kidney inflammation, and erectile dysfunction, which are increasingly common globally. With the increasing focus on research and development activities that emphasize L-arginine and its potential applications, the industry is expected to experience growth. Furthermore, the market is expected to benefit from the innovation of key players and the growing trend of online sales.

Restrain

The industry is currently facing continuous price competition, which may be significantly impacted by emerging competitors operating production bases in China and Southeast Asia. To address this challenge, the company plans to reduce costs and introduce high-value-added products that integrate its proprietary technologies, anticipating that price competition will intensify in the future. However, if the company's rivals introduce products at prices it cannot match, or if customer preferences change, the company's profitability may decline, and its financial performance may suffer.

Trend

Recent advancements in L-arginine research include the cloning of complementary DNA for agmatinase, N-acetylglutamate synthetase, and proteins responsible for transporting arginine to the mitochondria. These developments have led to investigations into their regulation and tissue-specific expression. Furthermore, new studies have highlighted the arginases' roles in health and disease, impacting nitric oxide, proline, or polyamine synthesis and the expression of specific genes. The ability to limit free arginine availability is a contributing factor to these outcomes.